Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Safety and Effectiveness of Remifentanil With a Combination of Remimazolam and Dexmedetomidine for Awake Fibreoptic Nasotracheal Intubation

NCT06581731 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT06581731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06581731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Safety and Effectiveness of Remifentanil With a Combination of Remimazolam and Dexmedetomidine for Awake Fibreoptic Nasotracheal Intubation
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Not applicable
Overall status
Completed
Start date
June 14, 2024
Completion date
March 4, 2026
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

difficult or failed intubation, sedative adverse reaction